The continuing search for effective treatments for men with hormone refractory prostate cancer (HRPC) has been a long and not very successful story. To date, under scientific conditions, the only chemotherapy which has demonstrated any survival benefit for men with prostate cancer has been docetaxel with prednisone. However, the survival benefit is very limited, only [...]
I have received a number of e-mails from men who are both frustrated that Provenge is not yet approved and who are frustrated that even when approved they will not qualify to get the treatment. I understand the frustration and feel the same way. The first question is will the FDA approve Provenge? Only time [...]
Now is a time to reflect, remember and renew ourselves. At this season the world is reawakening and so should our spirits. Now is the time to go out and see the flowers as they peek out of the ground. Now is the time to take in a deep breath and smell the fresh air. [...]
I often try and steer a little clear of the most controversial of issues effecting those of us with prostate cancer, but despite personal opinions, the recent health care reform passed in the United States requires discussion. The reform legislation, besides representing the most sweeping social policy change in the U.S. in decades will have [...]
According to a study issued by Health Grades, an independent health care ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average! The study also found that hospitals that have received the Stroke Certification from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) [...]